WO2023144642A1 - Dispositifs prothétiques implantables ayant des coques externes avec échafaudage intégré pour améliorer la stabilité de forme, réduire le plissement et réduire le poids des dispositifs prothétiques implantables - Google Patents

Dispositifs prothétiques implantables ayant des coques externes avec échafaudage intégré pour améliorer la stabilité de forme, réduire le plissement et réduire le poids des dispositifs prothétiques implantables Download PDF

Info

Publication number
WO2023144642A1
WO2023144642A1 PCT/IB2023/050258 IB2023050258W WO2023144642A1 WO 2023144642 A1 WO2023144642 A1 WO 2023144642A1 IB 2023050258 W IB2023050258 W IB 2023050258W WO 2023144642 A1 WO2023144642 A1 WO 2023144642A1
Authority
WO
WIPO (PCT)
Prior art keywords
scaffold
shell
silicone
implantable prosthetic
prosthetic device
Prior art date
Application number
PCT/IB2023/050258
Other languages
English (en)
Inventor
Joseph Henry CONTILIANO
Michael Hoffman
Lucas HELDMAN
Vikram GARADI
Sriram Natarajan
Original Assignee
Mentor Worldwide Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/965,961 external-priority patent/US20230233737A1/en
Application filed by Mentor Worldwide Llc filed Critical Mentor Worldwide Llc
Publication of WO2023144642A1 publication Critical patent/WO2023144642A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/12—Mammary prostheses and implants

Definitions

  • the present patent application is generally related to medical devices, and is more specifically related to implantable prosthetic devices such as gel breast implants.
  • Implantable prosthetic devices such as breast implants, are commonly used to replace or augment body tissue.
  • body tissue In the case of the female breast, it may become necessary to remove some or all of the mammary gland and surrounding tissue in order to treat breast cancer. This surgery typically leaves a void that may be filled with an implantable prosthetic device that supports surrounding tissue and provides a normal body appearance, eliminating much of the shock and depression that often follows breast cancer surgeries.
  • Implantable prosthetic devices are also used for breast augmentation procedures.
  • Implantable prosthetic devices usually include a shell made of silicone or a biocompatible polymer. Shells are typically manufactured by dipping an appropriately sized and shaped mandrel into silicone. The mandrel may be solid or hollow. In other methodologies, a silicone solution may be sprayed onto the mandrel and allowed to cure. Hollow molds may also be used for forming the shells of implantable prosthetic devices.
  • a mandrel When a mandrel is used for making an implant, the process results in the formation of a shell having a mandrel opening, e.g., a circular hole, in one of its faces. After the shell has been formed, it must be removed from the mandrel. The mandrel opening is subsequently covered with a patch that seals the hole to form a fluid impervious implant shell. The completed shell can remain unfilled, be pre-filled, or intraoperatively filled through a small fill port or valve with a solution such as gel, saline, foam, or combinations of these materials.
  • a solution such as gel, saline, foam, or combinations of these materials.
  • silicone breast implants are not completely filled with solution. This situation may result in the formation of a dimple or concavity at the apex of the implant, which is commonly referred to as the ashtray effect.
  • the ashtray effect is frequently most evident when the implant is positioned atop a flat surface.
  • FIG. 40 shows a conventional breast implant 50 having an apex 52 at an upper end thereof, a base 54 at a lower end thereof, a radius 56 that extends around the circumference of the implant, and a dome 58 having a convexly curved surface that extends between the apex 52 and the radius 56.
  • the astray effect may result (i.e. , the presence of dimples, depressions, or concavities at the apex).
  • Many efforts have been directed to eliminating the ashtray effect including upside down curing and adding extra gel. Both approaches may increase the cost of an implant or involve expensive tooling. Adding extra gel may also add additional weight to the implant, which is not desirable.
  • upside down curing has not been deemed to efficiently remove the ashtray effect.
  • FIG. 41 shows a breast implant 70 having ripples 72. Avoiding or minimizing the occurrence of ripples has become an issue of enhanced importance with the increase of pre-pec procedures whereby implants are placed above the pectoralis muscle and closer to the skin. In any event, wrinkles and rippling are not desirable and technologies to reduce or eliminate their occurrence are sought without increasing the amount of gel, increasing shell tension, and/or increasing the outer diameter of the implant.
  • a conventional implant 80 has an upper pole 82 and a lower pole 84.
  • creases 86 are shown on the upper pole 82 of the anterior face.
  • the creases 86 i.e., scalloping
  • the creases formed in the anterior face can be discerned through the skin of the patient and are not aesthetically desirable.
  • breast implant manufacturers provide breast implants 90 that are more fully filled with gel or saline solution.
  • Many conventional implants contain about 400cc of gel or saline.
  • an additional 65cc of gel or saline is introduced into the shell.
  • the additional gel or saline added to the shell of the implant 90 improves the projection of the apex 92 of the implant.
  • increasing the volume of gel or saline within the implant 90 adds additional weight to the implant, and increases the tension on the shell. The additional weight may lead to problems such as back pain for patients.
  • the fatigue strength of a shell and/or implant is an important characteristic for providing for a long product life.
  • One way to increase fatigue strength is to increase shell thickness, however, this may adversely affect the natural feel of the implant as thinner shells typically feel more natural.
  • implant shells having improved fatigue strength while maintaining normal shell thickness and a more natural feel.
  • the form stability i.e., the ability of an implant to maintain its shape
  • Current means to afford improved form stability are directed toward increasing the cohesiveness of the gel that fills the implant. Increased gel cohesiveness changes the feel of the implant to less soft and less natural.
  • Conventional prosthetic implants typically include a silicone shell that is filled with a silicone gel.
  • the shell is designed to be soft and not structurally rigid.
  • the silicone gel that is used to fill the shell tends to bond to the inner surface of the shell, whereupon the gel can pull on the outerwall of the shell, which creates undesirable folds, wrinkles and/ordimples in the shell.
  • the shell has an outer surface and an inner surface that surrounds an interior volume of the shell.
  • One or more ribs are integrally formed with the inner surface of the shell and project inwardly from the inner surface of the shell into the interior volume of the shell.
  • the interior volume of the shell is filled with a biocompatible filler material, such as silicone gel.
  • the one or more ribs function as shell stiffeners to enhance the structural integrity and stability of the shell, to enhance the projection of the apex of the shell, and to minimize the occurrence of the ashtray effect, rippling, wrinkling, and/or scalloping.
  • an implantable prosthetic device such as a breast implant, preferably includes a shell made of a biocompatible elastomeric material (e.g., silicone), the shell having a front portion and a base that cooperatively surround an interior volume of the shell.
  • a biocompatible elastomeric material e.g., silicone
  • the biocompatible elastomeric material used to make the shell may be silicone or a polymer.
  • the implantable prosthetic device desirably includes a scaffold that is disposed within the interior volume of the shell.
  • the scaffold may be made of a polymeric material such as silicone.
  • the scaffold has an inner surface that faces toward the base of the shell and an outer surface that faces toward the front portion of the shell.
  • a biocompatible filler material e.g., silicone gel
  • the scaffolds disclosed in the present patent application preferably improve form stability or the ability of an implant to maintain its shape.
  • the scaffolds disclosed herein preferably increase strength and rigidity without increasing the shell wall thickness, thus maintaining softness while improving form stability.
  • the outer shell is filled with the biocompatible filler material (e.g., a gel; a silicone gel) that contacts and/or adheres to one or more surfaces of the scaffold.
  • the biocompatible filler material e.g., a gel; a silicone gel
  • the scaffold may be placed within the biocompatible filler material of the implantable prosthetic device prior to curing the biocompatible prosthetic material.
  • the scaffold is designed to replace a small portion (by weight) of the biocompatible filler material (e.g., silicone gel) that fills the outer shell of the implantable prosthetic device.
  • the biocompatible filler material e.g., silicone gel
  • the scaffold may be positioned symmetrically within the center of the implant.
  • the scaffold may be positioned (e.g., centered) over a base or rear wall of the outer shell.
  • the scaffold has sufficient mechanical integrity and bonds to the biocompatible filler material in such a way that it "scaffolds" the biocompatible filler material (i.e., reduces the ability of the biocompatible filler material to flow freely within the shell).
  • the scaffold helps to maintain the shape of the filled implant device, thereby enhancing the form stability of the implant.
  • the scaffold provides form stability for a gel-filled implant by maintaining the shape of the gel-filled implant, such as after the implant has been rotated 90 degrees into a vertical orientation (i.e., the position assumed when a woman with breast impiants stands up.)
  • a vertical orientation i.e., the position assumed when a woman with breast impiants stands up.
  • the shell of the gel-filled implant will maintain its original shape when it is rotated from a horizontal configuration (i.e., sitting on flat surface) to the vertical orientation.
  • the scaffold may be made of silicone. In other embodiments, the scaffold may be made of other polymeric materials, particularly those that will bond with the biocompatible filler materials used to fill the shell of the implant.
  • the internal scaffolding also provides form stability without having to increase the cohesiveness of the gel or the volume of gel that is introduced into the shell, thus minimizing the firmness of the device and minimizing the overall weight of the device.
  • Heavier implant devices may increase the potential for back issues (e.g., back pain) due to the extra weight of the implant. Using lighter implants helps to avoid the problems associated with heavier devices.
  • the scaffold has a concave inner surface that faces toward the base of the shell.
  • many different scaffold geometries that have a concave inner surface may be utilized.
  • the biocompatible filler material e.g., a cohesive filler material; a silicone gel
  • the concave geometry of the scaffold preferably acts like a honeycomb to limit the flow of the biocompatible filler material within the shell.
  • the biocompatible filler material disposed within the interior volume of the shell is adhered to at least a portion of the inner surface or the outer surface of the scaffold.
  • the inner surface of the scaffold may be concave, and the outer surface of the scaffold may be convexly curved.
  • the convexly curved outer surface of the scaffold preferably mirrors the shape of the front portion of the shell.
  • the scaffold may have one or more openings (e.g., round holes; slits; squares; rectangles) formed therein that extend from the inner surface of the scaffold to the outer surface of the scaffold.
  • openings can be of any known geometry (e.g., round; square; rectangular; elongated slit; triangle).
  • the scaffold is attached to the base of the shell.
  • the scaffold may have a general shape that is akin to the appearance of a hemisphere having an open base at a lower end thereof.
  • the scaffold may have a concave shape.
  • the scaffold may have a concave inner surface and a convexly curved outer surface.
  • the scaffold has a lower end including a circular, free edge that surrounds the open base of the scaffold.
  • the scaffold may have an inwardly projecting rim that is located at the base (i.e., lower end) of the scaffold and that extends around an opening formed in the base of the scaffold.
  • the scaffold may include a wall having a curvature that extends between the radius or side of the scaffold and the rim that projects inwardly at the base of the scaffold.
  • the circular, free edge of the scaffold is juxtaposed with the base of the shell.
  • the circular, free edge of the scaffold may be attached to the base of the shell.
  • the circular, free edge of the scaffold is not attached to the base of the shell.
  • the front portion of the shell preferably includes an apex and a dome that extends between the apex and the base of the shell.
  • an implantable prosthetic device may include a second scaffold that is nested within the first scaffold.
  • the second scaffold is located between the inner surface of the first scaffold and the base of the shell.
  • the first scaffold has an inner dimension that is larger than the outer dimension of the second scaffold that is nested inside the first scaffold.
  • the first scaffold has a greater height than the second scaffold.
  • the base of the first scaffold has an outer diameter that is greater than the outer diameter of the open base of the second scaffold.
  • the second scaffold has one or more openings formed therein that extend from an inner surface to an outer surface of the second scaffold.
  • the biocompatible filler material that is used to fill the shell is desirably in contact with at least one of the inner and outer surfaces of the second scaffold.
  • the front portion of the shell has a shell wall thickness
  • the first scaffold has a first scaffold wall thickness
  • the second scaffold has a second scaffold wall thickness
  • the second scaffold wall thickness is greater than the first scaffold wall thickness.
  • the wall thicknesses of the respective first and second scaffolds may be the same or similar.
  • the first scaffold wall thickness is greater than the shell wall thickness. In one embodiment, the first scaffold wall thickness is the same as the shell wall thickness.
  • the second scaffold may have a geometric shape that is different than the geometric shape of the first scaffold or the geometric shape of the front portion of the shell.
  • the first scaffold may have a geometric shape that is different than the geometric shape of the second scaffold or the geometric shape of the front portion of the shell.
  • the shell has a shell wall thickness
  • the scaffold has a scaffold wall thickness that is greater than the shell wall thickness
  • the scaffold has an apex, a radius, and a dome that extends between the apex of the scaffold and the radius of the scaffold.
  • the scaffold has a wall that is thicker at the apex of the scaffold and thinner at the radius of the scaffold.
  • an implantable prosthetic device preferably includes a silicone shell having a front wall portion and a base that surround an interior volume of the shell.
  • a silicone scaffold is disposed within the interior volume of the silicone shell.
  • the silicone scaffold desirably has a concave inner surface that faces toward the base of the silicone shell and a convexly curved outer surface that faces toward the front wall portion of the silicone shell.
  • a silicone gel is disposed within the interior volume of the shell.
  • the silicone gel preferably fills the silicone shell and surrounds the silicone scaffold.
  • the silicone scaffold has one or more openings formed therein that extend from the concave inner surface of the silicone scaffold to the convexly curved outer surface of the silicone scaffold.
  • the silicone scaffold has the shape of a hemisphere having an open base and a lower, free edge that surrounds the open base.
  • the lower, free edge of the silicone scaffold may have the shape of a circle.
  • the lower, free edge of the silicone scaffold is juxtaposed with the base of the silicone shell.
  • the lower, free edge of the silicone scaffold is attached to the base of the silicone shell.
  • the implantable prosthetic device preferably includes a second silicone scaffold that is nested within the first silicone scaffold and that is located between the concave inner surface of the first silicone scaffold and the base of the silicone shell.
  • the front wall of the silicone shell desirably includes an apex, and a dome that extends between the apex and the base of the silicone shell.
  • the silicone scaffold has a geometric shape that mirrors the geometric shape of the dome of the silicone shell.
  • the front wall portion of the silicone shell has a first wall thickness
  • the silicone scaffold has a second wall thickness that is greater than the first wall thickness
  • the shells may be made by dipping or spraying a mandrel with a biocompatible, curable material such as silicone, polymers, polyurethane, silicone-polyurethane co-polymers, elastomers or combinations thereof. After application of the biocompatible, curable material to the mandrel, the curable material is allowed to cure, and the cured shell is removed from the mandrel.
  • a biocompatible, curable material such as silicone, polymers, polyurethane, silicone-polyurethane co-polymers, elastomers or combinations thereof.
  • the scaffold may be formed from the same material as the shell.
  • the scaffold may be formed from a different material than that of the shell (e.g., a different silicone or the same silicone further cross-linked).
  • the scaffold may be a composite of a second material that is embedded within the scaffold (e.g., a monofilament or multifilament structure that is either polymeric (e.g., suture material) or metallic (e.g., a thin wire).
  • the second material may be embedded during a layering or molding process used to form the scaffold.
  • the shell has an outer surface that is smooth and an inner surface that surrounds an interior volume of the shell.
  • a biocompatible filler material e.g., gel
  • the shell may be filled with 80cc - 1 ,445cc of the biocompatible filler material.
  • the scaffold may have holes or ports formed therein to allow the gel to flow between the interior and exterior regions of the scaffold.
  • providing gel outside the scaffold is beneficial because the gel is generally soft to the touch.
  • the scaffold inhibits the type of gel flow found in prior art devices that tends to pull and distort the shape of the shell.
  • the scaffold disclosed in the present patent application provides a unique shape maintaining effect.
  • an implantable prosthetic device having a scaffold incorporated therein has the appearance of an implant that has been filled with extra gel, but without requiring the extra gel. Rather than using extra gel to provide more form stability, the scaffold disclosed in the present patent application functions as a substitute for the need to use extra gel, which reduces firmness and the overall weight of the implant.
  • FIG. 1A is a perspective view of an implantable device including an outer shell, in accordance with one embodiment of the present patent application.
  • FIG. 1 B is a front elevation view of the implantable device shown in FIG. 1 A.
  • FIG. 2 is a cross-sectional view of the implantable device shown in FIGS. 1 A and 1 B including the outer shell, a scaffold disposed within the outer shell, and a gel contained within the outer shell and engaging a surface of the scaffold, in accordance with one embodiment of the present patent application.
  • FIG. 3 is a cross-sectional view of the implantable device shown in FIG. 1 B including the outer shell, the scaffold, and the silicone gel contained within the outer shell and in contact with at least the surface of the scaffold.
  • FIG. 4A is a side elevation view of a scaffold for an implantable device.
  • the scaffold having a dome-shaped wall and openings formed in the dome-shaped wall.
  • FIG. 4B is a perspective view of an underside of the scaffold shown in FIG. 4A.
  • FIG. 5 is a perspective view of an implantable device including an outer shell, a scaffold disposed within the outer shell, and a silicone gel contained within the outer shell and in contact with at least one surface of the scaffold disposed within the outer shell, in accordance with one embodiment of the present patent application.
  • FIG. 6 shows the implantable device of FIG. 5 when the device is rotated 90° in the vertical orientation.
  • FIG. 7 is a schematic, cross-sectional view of an outer shell of an implantable device, in accordance with one embodiment of the present patent application.
  • FIG. 8 is a schematic, cross-sectional view of a first scaffold having a first outer dimension and a second scaffold having a second outer dimension that is smaller than the first outer dimension, in accordance with one embodiment of the present patent application.
  • FIG. 9 is a schematic, cross-sectional view of the outer shell of FIG. 7 with the first and second scaffolds of FIG. 8 disposed within the outer shell, in accordance with one embodiment of the present patent application.
  • FIG. 10 is a schematic, cross-sectional view of an outer shell of an implantable device, in accordance with one embodiment of the present patent application.
  • FIG. 11 is a schematic, cross-sectional view of a scaffold configured for being disposed within the outer shell of FIG. 10, the scaffold having a dome-shaped wall with a plurality of slits formed in the dome-shaped outer wall.
  • FIG. 12 is a cross-sectional view of the shell shown in FIG. 10 with the scaffold of FIG. 11 disposed within the outer shell, in accordance with one embodiment of the present patent application.
  • FIG. 13 is a schematic, cross-sectional view of an outer shell of an implantable device, in accordance with one embodiment of the present patent application.
  • FIG. 14 is a schematic, cross-sectional view of a scaffold for an implantable device, the scaffold having a dome-shaped wall with an apex region having a first thickness and a radial region having a second thickness that is less than the first thickness, in accordance with one embodiment of the present patent application.
  • FIG. 15 shows the outer shell of FIG. 13 with the scaffold of FIG. 14 disposed therein, in accordance with one embodiment of the present patent application.
  • FIG. 16 is a schematic, cross-sectional view of an outer shell of an implantable device, in accordance with one embodiment of the present patent application.
  • FIG. 17 is a schematic, cross-sectional view of a scaffold having a dome-shaped outer wall with an inner surface that is concave and an outer surface that is asymmetric, in accordance with one embodiment of the present patent application.
  • FIG. 18 shows the outer shell of FIG. 16 with the scaffold of FIG. 17 contained therein, in accordance with one embodiment of the present patent application.
  • FIG. 19 is a schematic, cross-sectional view of an outer shell of an implantable device, in accordance with one embodiment of the present patent application.
  • FIG. 20 is a schematic, cross-sectional view of a scaffold that is configured to be disposed within the outer shell of FIG. 19, the scaffold having a dome-shaped wall with an inner surface including ribs, in accordance with one embodiment of the present patent application.
  • FIG. 21 shows the outer shell of FIG. 19 with the scaffold of FIG. 20 disposed therein, in accordance with one embodiment of the present patent application.
  • FIG. 22 is a schematic, cross-sectional view of a shell of an implantable device, in accordance with one embodiment of the present patent application.
  • FIG. 23 is a schematic, cross-sectional view of a scaffold configured for being disposed within the outer shell of FIG. 22, the scaffold having a dome-shaped wall with a rim that projects inwardly at a lower end of the scaffold to define an open base.
  • FIG. 24 is a cross-sectional view of the shell shown in FIG. 22 with the scaffold of FIG. 23 disposed within the outer shell, in accordance with one embodiment of the present patent application.
  • FIG. 25 is a schematic, cross-sectional view of an outer shell of an implantable device, in accordance with one embodiment of the present patent application.
  • FIG. 26 is a schematic, cross-sectional view of a first scaffold having a first outer dimension and a second scaffold having a second outer dimension that is smaller than the first outer dimension, in accordance with one embodiment of the present patent application.
  • FIG. 27 is a schematic, cross-sectional view of the outer shell of FIG. 25 with the first and second scaffolds of FIG. 26 disposed within the outer shell, in accordance with one embodiment of the present patent application.
  • FIG. 28 is a schematic, cross-sectional view of an outer shell of an implantable device, in accordance with one embodiment of the present patent application.
  • FIG. 29 is a schematic, cross-sectional view of a scaffold that is configured to be disposed within the outer shell of FIG. 28, in accordance with one embodiment of the present patent application.
  • FIG. 30 shows the outer shell of FIG. 28 with the scaffold of FIG. 29 disposed therein, and struts extending between the scaffold and the shell, in accordance with one embodiment of the present patent application.
  • FIG. 31 is a schematic, cross-sectional view of an outer shell of an implantable device, in accordance with one embodiment of the present patent application.
  • FIG. 32 is a schematic, cross-sectional view of a scaffold that is configured to be disposed within the outer shell of FIG. 31 , the scaffold having a dome-shaped wall with an outer surface including ribs, in accordance with one embodiment of the present patent application.
  • FIG. 33 shows the outer shell of FIG. 31 with the scaffold of FIG. 32 disposed therein, and the ribs maintaining spacing between the scaffold and the shell, in accordance with one embodiment of the present patent application.
  • FIG. 34 is a side elevation view of a scaffold for an implantable device, the scaffold including a dome-shaped wall with a plurality of openings formed in the dome-shaped wall, in accordance with one embodiment of the present patent application.
  • FIG. 35 shows a side elevation view of an implantable device including an outer shell and the scaffold of FIG. 34 disposed within the outer shell, the implantable device including a silicone gel contained within the outer shell that is contact with at least one surface of the scaffold, in accordance with one embodiment of the present patent application.
  • FIG. 36 shows the implantable device of FIG. 35 rotated 90 degrees in a vertical orientation.
  • FIG. 37 is a side elevation view of a scaffold of an implantable device, the scaffold including a dome-shaped wall having a plurality of openings formed therein, in accordance with one embodiment of the present patent application.
  • FIG. 38 is a side elevation view of an implantable device including an outer shell and the scaffold of FIG. 37 disposed within the outer shell, the implantable device including gel contained within the outer shell and in contact with at least one surface of the scaffold, in accordance with one embodiment of the present patent application.
  • FIG. 39 shows the implantable device of FIG. 38 after being rotated 90 degrees into a vertical orientation.
  • FIG. 40 shows a prior art implantable device.
  • FIG. 41 shows a prior art implantable device.
  • FIG. 42 shows a prior art implantable device.
  • FIG. 43 shows a prior art implantable device.
  • the elements of the implantable prosthetic devices disclosed herein may be defined as set forth below.
  • Implantable prosthetic device A mammary implant or tissue expander, which is filled with a biocompatible cohesive filler material such as a gel.
  • An implantable prosthetic device may be pre-filled, filled intraoperatively, or may be filled in situ. Breast implants are typically pre-filled.
  • the outer envelope of the implantable prosthetic device which contains the biocompatible filler material (e.g., a cohesive filler material; silicone gel).
  • the shell is typically made of biocompatible polymers such as silicone, however, other materials may be used.
  • the shell is also referred to as the outer shell.
  • Dome The rounded region of the shell running from the apex to the radius region.
  • Radial direction Running in general direction from the apex to the base of the shell and/or running in a plane that is perpendicular to the base.
  • Circumferential direction A direction that extends around the sides of an implantable prosthetic device and/or in a plane that is parallel with the base of the shell, such as the radius region of a breast implant or tissue expander.
  • an implantable prosthetic device 100 e.g., a breast implant
  • a shell 102 having an apex 104, a base 106, a radius 108 that extends around the side of the implantable prosthetic device 100, and a dome 110 that extends from the apex 104 to the radius 108.
  • the shell 102 of the implantable prosthetic device 100 preferably has an outer surface 112 and an inner surface 114.
  • the outer surface 112 of the shell 102 may have a section that is convexly curved and the inner surface 114 of the shell 102 may have a section that includes a concave curve.
  • the outer surface of the shell may be smooth or may have a textured surface.
  • the implantable device may include suture tabs that are attached to the shell for securing the shell to tissue using sutures.
  • the shell 102 may be formed by depositing (e.g., spraying, dipping) a biocompatible curable material over a convexly curved outer surface of a mandrel.
  • the curable material that is applied over the convexly curved outer surface of the mandrel may be a curable silicone material.
  • the curable silicone material may be sprayed over the outer surface of a mandrel, whereupon the curable material flows over the convexly curved surface.
  • the curable silicone material may be applied by dipping the mandrel in a curable silicone solution.
  • the shell may have multiple layers that are built up over the convexly curved outer surface of the mandrel using multiple spraying and/or dipping steps, whereby multiple layers of the curable material are deposited for increasing the wail thickness of shell.
  • the shell 102 may be made using one or more of the systems, devices and methods disclosed in U.S. Patent No. 4,472,226 to Redinger et al., U.S. Patent Application Publication No. US 2014/0088703 to Schuessler, or U.S. Patent No. 10,898,313, the disclosures of which are hereby incorporated by reference herein.
  • the shell 102 has an interior volume or interior chamber that may be filled with a biocompatible filler material.
  • the biocompatible filler material may include a gel, saline, water, air, a biocompatible gas (e.g., nitrogen), or combinations thereof.
  • the biocompatible filler material that fiils the interior volume of the shell 102 is a silicone gel, which may be uncured, partially cured, or fully cured.
  • the implantable prosthetic device 100 preferably includes a scaffold 116 (e.g., a buttress; a support; a brace) that is disposed within the interior volume of the shell 102.
  • the scaffold 116 may have the shape of a hollow hemisphere.
  • the scaffold 116 may include a dome-shaped wall 118 having a concave bottom surface 120 that faces toward the base 106 of the shell 102 and a convexly curved top surface 122 that faces toward the apex 104 of the shell 102.
  • the dome-shaped wall 118 of the scaffold 116 preferably includes an apex 124, a radius 126, and a dome region 128 that extends between the apex 124 and the radius 126.
  • the scaffold 116 preferably has an open base 130 that is positioned over the base 106 of the outer shell 102.
  • the open base 130 of the scaffold 116 is surrounded by a free edge 132 of the outer wall 118 of the scaffold 116.
  • the free edge 132 of the scaffold may have a circular shape.
  • the base of the scaffold may include a rim that projects inwardly from an outer perimeter.
  • the rim may have an inner edge that surrounds an opening formed in the base of the scaffold.
  • the scaffold may include a wall having a curved region that extends between the radius or side of the scaffold and the rim that projects inwardly at the base of the scaffold.
  • the scaffold 116 may have the appearance of a hollow sphere that has been cut in half by a horizontal plane to form a hollow hemisphere having the open base 130 that is surrounded by the circular, free edge of the dome-shaped wall 118 of the scaffold 116.
  • the scaffold 116 may be made of the same material that is used to make the shell 102.
  • the scaffold may be made of a material that is different than the material that is used to make the shell.
  • the wall of the shell 102 has a first thickness T1 that is smaller than the second thickness T 2 of the wall 118 of the scaffold 116.
  • the thickness of the wall 118 of the scaffold 116 may vary between the apex 124 of the scaffold and the radius 126 of the scaffold.
  • a biocompatible filler material 134 such as a silicone gel, may be disposed within the interior volume of the shell 102 of the implantable prosthetic device 100.
  • the biocompatible filler material 134 preferably fills the interior volume of the shell 102 and surrounds the scaffold 116 that is contained within the shell 102.
  • the biocompatible filler material 134 is adhered to one or more surfaces 120, 122 of the wall 118 of the scaffold 116.
  • the scaffold 116 preferably overlies an inner surface of the base 106 of the shell 102. In one embodiment, the scaffold 116 may be centered over the base 106 of the shell 102.
  • the circular, free edge 132 of the scaffold 116 is preferably juxtaposed with the inner surface of the base 106 of the shell 102. In one embodiment, the circular, free edge 132 of the scaffold 116 may be adhered and/or secured to the inner surface of the base 106 of the scaffold 116. In one embodiment, the circular, free edge 132 of the scaffold 116 is not adhered to the inner surface of the base 106 of the scaffold 116.
  • the shell 102 has a first outer diameter OD 1 that is larger than the second outer diameter OD 2 of the scaffold 116. In one embodiment, the shell 102 has a first inner diameter ID 1 that is larger than the second outer diameter OD 2 of the scaffold 116.
  • the scaffold 116 is disposed within the shell 102 of the implantable device 100.
  • the dome-shaped wall 118 of the scaffold 116 has the circular, free edge 132 that surrounds the open base 130 of the scaffold 116.
  • the circular, free edge 132 is spaced inwardly and away from the outer perimeter of the shell 102.
  • the circular, free edge 132 of the deme-shaped wall 118 of the scaffold 116 may be centered overthe base 106 (FIG. 2) of the shell 102 of the implantable device 100.
  • the shell 102 has a first outer diameter OD 1 that is larger than the second outer diameter OD 1 of the scaffold 116.
  • the biocompatible filler material 134 preferably fills the interior volume of the shell 102.
  • the biocompatible filler material is in contact with one or more of the major surfaces 120, 122 of the dome-shaped wall 118 of the scaffold 116.
  • the biocompatible filler material is adherent to one or more of the major surfaces of the scaffold.
  • the biocompatible filler material completely fills the interior volume of the shell and the interior volume of the scaffold that is disposed inside the shell.
  • the biocompatible filler material is disposed between the outer surface 122 of the scaffold 118 and the inner surface of the wall of the shell 102.
  • a scaffold 216 for an implantable prosthetic device preferably includes an outer wall 218 having a dome- shape with an open base 230.
  • the scaffold 216 may be made of a biocompatible material, such as a biocompatible polymer (e.g., silicone).
  • the scaffold 216 may have the shape of hollow hemisphere having a lower end with an open base 230 that is surrounded by a circular, free edge 232 of the outer wall 218.
  • the circular, free edge 232 preferably extends around the outer perimeter of the open base 230 of the scaffold 216.
  • the dome-shaped wall 218 of the scaffold 216 preferably includes a plurality of openings 236 formed therein that extend between the inner surface 220 and the outer surface 222 of the outer wall 218 of the scaffold 216.
  • the openings 236 may have various geometric shapes including circles. In other embodiments, the openings may be elongated and/or may include slits that are formed in the outer wall 218 and that extend from the outer surface to the inner surface of the dome-shaped wall 218.
  • the openings 236 may have other geometric shapes, including, but not limited to, squares, rectangles, polygons, and triangles.
  • the scaffold 216 shown and described above in FIGS. 4A and 4B may be disposed within a shell 202 of an implantable prosthetic device 200.
  • the open base 230 (FIG. 4B) of the scaffold 216 is preferably juxtaposed with the base 206 (i.e., a rear wall) of the shell 202.
  • the circular, free edge 232 (FIG. 4B) of the dome-shaped wall 218 of the scaffold 216 preferably abuts against and/or is juxtaposed with an inner surface of the base 206 of the shell 202.
  • the shell 202 is preferably filled with a biocompatible filler material (e.g., a silicone gel), which completely fills the interior volume of the shell 202 and is adherent to one or more major surfaces of the dome-shaped wall 218 of the scaffold 216.
  • a biocompatible filler material e.g., a silicone gel
  • the biocompatible filler material that fills the interior volume of the shell 202 may pass through the one or more of the openings 236 (FIG. 4B) formed in the dome-shaped wall 218 of the scaffold 216.
  • FIG. 5 the shell 202 of the implantable prosthetic device 200 is in a horizontal orientation with the base 206 of the shell 202 overlying a horizontal surface.
  • FIG. 6 shows the implantable prosthetic device 200 of FIG. 5 after the shell 202 has been rotated 90 degrees in a clockwise direction relative to the horizontal orientation shown in FIG. 5.
  • the shell 202 may be described as being in a vertical orientation.
  • the scaffold 216 that is disposed inside the shell 202 of the implantable device 200 preferably provides an internal reinforcement for the shell that maintains the shape and form stability of the shell.
  • the base 206 of the shell, reinforced by the scaffold 216 extends along a vertical axis and the shell does not lose its shape as occurs with the prior art implants shown in FIGS. 28-31 of the present patent application.
  • an implantable prosthetic device 300 preferably includes a shell 302 having a front wall 305 and a rear wall 306 (i.e., a base).
  • the front wall 305 of the shell 302 may include an apex 304, a radius 308, and a dome 310 that extends between the apex 304 and the radius 308.
  • the implantable prosthetic device preferably includes a first scaffold 316A having a first dimension and a second scaffold 316B having a second dimension that is smaller than the first dimension of the first scaffold 316A.
  • the second scaffold 316B is configured for nesting inside the first scaffold 316A.
  • the first scaffold 316A defines a first height H 1 and an outer diameter OD 3 .
  • the second scaffold 316B defines a second height H 2 and an outer diameter OD 2 .
  • the first height H 1 of the first scaffold 316A is greater than the second height H 2 of the second scaffold 316B.
  • the outer diameter OD 3 of the first scaffold 316A is greater than the outer diameter OD 4 of the second scaffold 316B.
  • the first and second scaffolds 316A, 316B are disposed within the interior volume of the shell 302 of the implantable device 300.
  • the second scaffold 316B is nested within the first scaffold 316A.
  • the first and second scaffolds preferably have open bases so that circular, free edges 332A, 332B of the respective first and second scaffolds are juxtaposed with the inner surface of the rear wall 306 of the shell 302 of the implantable device 300.
  • the second scaffold 316B may have a wall thickness that is greater than the wall thickness of the first scaffold 316A.
  • the first scaffold 316A may have a wall thickness that is greater than the wall thickness of the shell 302 of the implantable device 300.
  • the first and second scaffolds 316A, 316B may have respective wall thicknesses that are equal and/or similar to one another.
  • an implantable prosthetic device may include three or more scaffolds that are preferably nested within one another and that are disposed inside a shell of the implantable prosthetic device. Each of the three or more scaffolds preferably has a different size.
  • the shell 302 of the implantable prosthetic device 300 is preferably filled with a gel, such as a silicone gel.
  • a gel such as a silicone gel.
  • the silicone gei preferably engages one or more surfaces of the first and second scaffolds 316A, 316B.
  • an implantable prosthetic device 400 preferably includes a shell 402 having a front wall 405 and a rear wall 406.
  • a scaffold 416 is configured for being disposed within the interior volume of the shell 402 of the implantable prosthetic device 400 shown in FIG. 10.
  • the scaffold 416 preferably includes a wall 418 having a dome shape and an open base 430 surrounded by a circular, free edge 432 of the dome-shaped wall 418.
  • the dome-shaped wall 418 of the scaffold 416 has a plurality of silts 436 (e.g., elongated openings) formed therein that extend between an inner surface 420 and an outer surface 422 of the dome-shaped wall 418 of the scaffold 416.
  • the scaffold 416 is disposed within the shell 402 so that the circular, free edge 432 of the scaffold that surrounds the open base 430 of the scaffold 416 is juxtaposed with an inner surface of the rear wall 406 of the shell 402.
  • the scaffold is centered over the rear wall 406 of the shell 402.
  • the circular, free edge of the scaffold may be adhered to the rear wall 406 of the shell 402.
  • the interior volume of the shell of the implantable prosthetic device 400 is preferably filled with a biocompatible filler material, such as a silicone gel, which is adhered to one or more major surfaces 420, 422 of the wall 418 of the scaffold 416.
  • a biocompatible filler material such as a silicone gel
  • an implantable prosthetic device 500 preferably includes a shell 502 (e.g., a silicone shell) having a front wall 505 and a rear wall 506 that is adapted to receive a scaffold (e.g., a reinforcing support; a buttress).
  • a scaffold e.g., a reinforcing support; a buttress.
  • a scaffold 516 adapted to be disposed within the interior volume of the shell 502 of FIG. 13.
  • the scaffold 516 preferably includes a wall 518 having a dome-shape with an open base 530 that is surrounded by a circular, free edge 532 of the wall 518 of the scaffold 516.
  • the dome-shaped wall 518 of the scaffold 516 preferably includes an apex 524, a radius 526, and a dome-shaped region 528 that extends between the apex 524 and the radius 526.
  • the wall 518 of the scaffold 516 is thicker in the apex region 524 thereof and thinner in the radius region 526 thereof.
  • the scaffold 516 is disposed within the interior volume of the shell 502 of the implantable prosthetic device 500.
  • the circular, free edge 532 that surrounds the open base 530 of the scaffold 516 is preferably juxtaposed with the inner surface of the rear wall 506 of the shell 502.
  • the circular, free edge 532 of the scaffold 516 may be adhered and/or connected with the rear wall 506 of the shell 502.
  • the shell 502 is preferably filled with a biocompatible filler material, such as a silicone gel.
  • a biocompatible filler material such as a silicone gel.
  • the silicone gel desirably adheres to one or more of the major surfaces 520, 522 of the wall 518 of the scaffold 516.
  • an implantable prosthetic device 600 preferably includes a shell 602 having a front wall 605 and a rear wall 606.
  • the shell 602 is configured for receiving a scaffold that provides form stability to the shell.
  • a scaffold 616 includes a curved wall 618 having a dome shape.
  • the scaffold 616 preferably has a hollow, hemispheric shape with an open base 630 that is surrounded by a circular, free edge 632 of the curved wall 618.
  • the curvature of the curved wall 618 of the scaffold 616 does not mirror the geometric shape or curvature of the front wall 605 of the shell 602.
  • the curvature of the wail 618 of the scaffold 616 is greater than the curvature of the front wall 605 of the outer shell 602 of the implantable prosthetic device 600.
  • the curvature and/or geometry of the wall 618 of the scaffold 616 neither matches nor mirrors the curvature and/or geometry of the front wall 605 of the shell 602 of the implantable prosthetic device 600.
  • the scaffold 616 is disposed within the shell 602 of the implantable prosthetic device 600.
  • the circular, free edge 632 of the wall 618 of the scaffold 616 is preferably juxtaposed with the rear wall 606 of the outer shell 602.
  • the curvature of the wall 618 of the scaffold 616 does not match the curvature of the front wall 605 of the outer shell 602.
  • the scaffold 616 is preferably centered over the rear wall 632 of the outer shell 602.
  • the circular, free edge 632 of the scaffold 616 may be secured and/or adhered to the inner surface of the rear wall 606 of the shell 602.
  • the interior volume of the shell 602 of the implantable device 600 is preferably filled with a biocompatible filler material (e.g., a silicone gel) that engages one or more of the major surfaces 620, 622 of the wall 618 of the scaffold 616.
  • a biocompatible filler material e.g., a silicone gel
  • an implantable prosthetic device 700 preferably includes a shell 702 having a front wall 705 and a rear wall 706.
  • a scaffold 716 is preferably configured for being disposed within the shell 702 of the implantable prosthetic device 700 shown and described above in FIG. 19.
  • the scaffold 716 preferably includes a wall 718 having a dome shape with a concave inner surface 720 and a convexly curved outer surface 722.
  • the scaffold 716 desirably includes an open base 730 that is surrounded by a circular, free edge 732 of the wall 718 of the scaffold 716.
  • the scaffold 716 preferably includes one or more ribs 750 that are connected with the inner surface 720 of the scaffold 716 and that project inwardly from the inner surface 720 of the wall 718 of the scaffold.
  • the ribs 750 may be integrally formed with the wall 718 of the scaffold 716.
  • the ribs 750 may be formed using one or more of the systems, devices and methods disclosed in commonly assigned U.S. Patent No. 10,898,313, the disclosure of which is hereby incorporated by reference herein.
  • the one or more ribs 750 preferably include a plurality of ribs that project inwardly from the inner surface of the wall 718 of the scaffold 716.
  • the ribs 750 may be spaced from one another over the inner surface 720 of the wall 718 for enhancing the structural stability of the scaffold 716.
  • the ribs 750 may extend in radial directions from the apex 724 of the scaffold to the base 730 of the scaffold.
  • the ribs 750 may extend in circumferential directions around the radius 726 of the scaffold 716.
  • the scaffold 716 having ribs 750 is preferably disposed within the shell 702 of the implantable prosthetic device 700.
  • the ribs 750 of the scaffold 716 desirably project from the inner surface of the wall 718 of the scaffold 716 and toward the rear wall 706 of the outer shell 702.
  • the circular, free edge 732 of the wall 718 of the scaffold 716 that surrounds the open base 730 is preferably juxtaposed with the rear wall 706 of the outer shell 702.
  • the circular, free edge 732 may be centered over the rear wall 706 of the outer shell 702.
  • the circular, free edge may be adhered to the rear wall 706 of the shell 702.
  • the shell 702 of the implantable device 700 is desirably filled with a biocompatible filler material (e.g., a silicone gel) that completely fills an interior chamber of the shell 702.
  • a biocompatible filler material e.g., a silicone gel
  • the biocompatible filler material is adhered to one or more of the inner and outer surfaces 720, 722 of the curved wall 718 of the scaffold 716.
  • an implantable device 800 preferably includes a shell 802 having a front wall 805 and a base 806, which may also be referred to as a rear wall.
  • a scaffold 816 has a base 830.
  • a portion of the base 830 may include a rim 855 that projects inwardly at the lower end of the scaffold 816.
  • the rim 855 preferably has a free edge 857 that extends around an opening 865 formed in the base 830.
  • the free edge 857 of the rim 855 may define the size of the opening 865 that is formed in the base 830.
  • an implantable prosthetic device 900 e.g., a breast implant
  • a shell 902 having a front wall 905 and a rear wall 906 (i.e., a base).
  • the implantable prosthetic device preferably includes a first scaffold 916A having a first dimension and a second scaffold 916B having a second dimension that is smaller than the first dimension of the first scaffold 916A.
  • the second scaffold 916B is configured for nesting inside the first scaffold 316A.
  • the first scaffold 916A has a base 930A with a rim 955A that extends inwardly at the base of the first scaffold.
  • the rim 955A has a free edge 957A that extends around an opening 965A formed in the base 930A.
  • the free edge 957A preferably defines the size of the opening 965A formed in the base 930A of the first scaffold 916A.
  • the second scaffold 916B has a circular, free edge 932B that defines the size of the opening 965B in the open base 930B of the second scaffold 916B.
  • the second scaffold 916B may be passed through the opening in the opening 965A in the base 930A of the first scaffold 916A for nesting the second scaffold inside the first scaffold.
  • the size of the opening 95B in the open base 930B of the second scaffold 916B is larger than the size of the opening 965A in the base 930A of the first scaffold 916A.
  • the first and second scaffolds 916A, 916B may be disposed within the interior volume of the shell 902 of the implantable device 900.
  • the second scaffold 916B is nested within the first scaffold 916A.
  • the circular, free edge 932B of the second scaffold 916B may be juxtaposed with an inner surface of the inwardly extending rim 955A of the first scaffold 916A, and the outer surface of the inwardly extending rim 955A of the first scaffold 916A may be juxtaposed with the inner surface of the base 906 of the shell 902 of the implantable device 900.
  • an implantable prosthetic device 1000 e.g., a breast implant preferably includes a shell 1002 having a front wall 1005 and a rear wall 1006 (i.e., a base).
  • the implantable prosthetic device 1000 preferably includes a scaffold 1016 that is adapted to be disposed within an interior chamber of the shell 1002 (FIG. 28).
  • the scaffold 1016 has an outer radius or dimension that is smaller than an inner radius or dimension of the front wall 1005 of the shell 1002.
  • the implantable prosthetic device 1000 preferably includes a plurality of struts 1075 (e.g., standoffs) that extend between the scaffold 1016 and the front wall 1005 of the shell 1002.
  • the struts 1075 preferably maintain spacing and/or standoff between the curved wall of the scaffold 1016 and the front wall 1005 of the shell 1002.
  • FIG. 30 is a schematic representation of an implant device having struts 1075 for providing spacing and/or standoff between the scaffold 1016 and the front wall 1005 of the shell 1002.
  • the number of struts 1075 extending between the scaffold and the front wall of the shell may be varied.
  • an implant device may have between two (2) to five struts.
  • an implant device may have 10, 15, 20, 25, 30, or more struts extending between the scaffold and the front wall of the shell 1002.
  • an implantable prosthetic device 1100 preferably includes a shell 1102 having a front wall 1105 and a rear wall 1106.
  • a scaffold 1116 is preferably configured for being disposed within the shell 1102 of the implantable prosthetic device 1100 (FIG. 31 ).
  • the scaffold 1116 preferably includes a wall 1118 having a concave shape with a concave inner surface 1120 and a convexly curved outer surface 1122.
  • the scaffold 1116 desirably includes an open base 1130 that is surrounded by a circular, free edge 1132 of the wall 1118 of the scaffold 1116.
  • the scaffold 1116 preferably includes one or more ribs 1150 that are connected with the outer surface 1122 of the scaffold 1116 and that project outwardly from the outer surface 1122 of the wall 1118 of the scaffold.
  • the ribs 1150 may be integrally formed with the wall 1118 of the scaffold 1116.
  • the ribs 1150 may be formed using one or more of the systems, devices and methods disclosed in commonly assigned U.S. Patent No. 10,898,313, the disclosure of which is hereby incorporated by reference herein.
  • the length and width of the ribs may be modified from what is shown schematically in FIG. 32.
  • the total number of ribs may be modified from what is shown schematically in FIG. 32.
  • the one or more ribs 1150 preferably include a plurality of ribs that project outwardly from the outer surface 1122 of the wall 1118 of the scaffold 1116.
  • the ribs 1150 may be spaced from one another over the outer surface 1122 of the wall 1118 for enhancing the structural stability of the scaffold 1116.
  • the ribs 1150 may extend in radial directions.
  • the scaffold 1116 having ribs 1150 may be disposed within the shell 1102 of the implantable prosthetic device 1100.
  • the ribs 1150 maintain spacing and/or provide standoff between the wall 1118 of the scaffold 1116 and the front wall 1105 of the shell 1102.
  • the circular, free edge 1132 of the wall 1118 of the scaffold 1116 is preferably juxtaposed with the base 1106 (i.e., rear wall) of the outer shell 1102.
  • the circular, free edge 1132 may be centered over the base 1106 of the outer shell 1102.
  • the circular, free edge may be adhered to the base 1106 of the shell 1102.
  • the shell 1102 of the implantable device 1100 is desirably filled with a biocompatible filler material (e.g., a cohesive filler material; a silicone gel) that fills an interior chamber of the shell 1102.
  • a biocompatible filler material e.g., a cohesive filler material; a silicone gel
  • the biocompatible filler material is adhered to one or more of the inner and outer surfaces 1120, 1122 of the curved wall 1118 of the scaffold 1116.
  • a scaffold 1216 for an implantable prosthetic device preferably includes a curved wall 1218 having an open base 1230 that is surrounded by a circular, free edge 1232.
  • the scaffold 1216 may have the shape of a hollow hemisphere.
  • the scaffold 1216 may be made of a biocompatible polymer such as a cured silicone gel.
  • the scaffold 1216 preferably includes a plurality of openings 1236 formed in the outer wall 1218 thereof that extend from an outer surface to an inner surface of the wall 1218 of the scaffold.
  • the scaffold 1216 is preferably disposed within a shell 1202 of an implantable prosthetic device 1200 so that the circular, free edge 1232 (FIG. 34) of the scaffold 1216 that surrounds the open base 1230 is juxtaposed with a rear wall 1206 of the shell 1202 of the implantable device 1200.
  • the scaffold 1216 may be centered over the rear wall 1206 of the shell 1202. The scaffold may be attached to the base of the shell.
  • the implantable prosthetic device 1200 includes a biocompatible filler material (e.g., a silicone gel) that fills the interior chamber of the shell 1202 and that is adherent to at least one of the inner and cuter surfaces of the curved wall 1218 of the scaffold 1216.
  • a biocompatible filler material e.g., a silicone gel
  • FIG. 353 the shell 1202 of the implantable prosthetic device 1200 is in a horizontal orientation with the rear wall 1206 of the shell 1202 overlying a horizontal surface.
  • FIG. 36 shows the implantable prosthetic device 1200 of FIG. 35 afterthe shell 1202 has been rotated 90 degrees in a clockwise direction relative to the horizontal orientation shown in FIG. 35.
  • the shell 1202 may be described as being in a vertical orientation.
  • the scaffold 1216 that is disposed inside the shell 1202 of the implantable device 1200 preferably provides an internal reinforcement for the shell that maintains the shape and form stability of the shell.
  • the rear wall 1206 of the shell, reinforced by the scaffold 1216 extends along a vertical axis and the shell does not lose its shape as occurs with the prior art implants shown in FIGS. 40-43 of the present patent application.
  • a scaffold 1316 for an implantable prosthetic device preferably includes a wall 1318 having a dome shape.
  • the wall 1318 may mirror the shape of a hollow hemisphere.
  • the scaffold 1316 preferably includes an open base 1330 that is surrounded by a circular, free edge 1332 of the dome-shaped wall 1318 of the scaffold.
  • a plurality of openings 1336 are formed in the curved wall 1318.
  • the openings 1336 in the wall 1318 preferably extend between an outer surface and an inner surface of the curved wall 1318.
  • the scaffold 1316 is disposed within an outer shell 1302 of an implantable prosthetic device 1300.
  • the circular, free edge 1332 of the curved wall 1318 of the scaffold 1316 that surrounds the open base 1330 (FIG. 37) is preferably juxtaposed with the rear wall 1306 of the shell 1302.
  • the shell 1302 of the implantable device 1300 is preferably filled with a biocompatible filler material such as a silicone gel.
  • the biocompatible filler material desirably completely fills the interior chamber of the shell 1302 and is preferably adherent to one or more of the inner and outer surfaces of the wall 1318 of the scaffold 1316 that is disposed within the shell 1302.
  • FIG. 38 the shell 1302 of the implantable prosthetic device 1300 is in a horizontal orientation with the rear wall 1306 of the shell 1302 overlying a horizontal surface.
  • FIG. 39 shows the implantable prosthetic device 1300 of FIG. 38 afterthe shell 1302 has been rotated 90 degrees in a clockwise direction relative to the horizontal orientation shown in FIG. 38.
  • the shell 1302 may be described as being in a vertical orientation.
  • the scaffold 1316 that is disposed inside the shell 1302 of the implantable device 1300 preferably provides an internal reinforcement for the shell that maintains the shape and form stability of the shell.
  • the rear wall 1306 of the shell, reinforced by the scaffold 1316 extends along a vertical axis and the shell does not lose its shape as occurs with the prior art implants shown in FIGS. 40-43 of the present patent application.

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

Un dispositif prothétique implantable, tel qu'un implant mammaire, comprend une coque constituée d'un matériau élastomère biocompatible. La coque a une partie avant et une base qui entourent un volume intérieur de la coque. Un échafaudage est disposé à l'intérieur du volume intérieur de la coque. L'échafaudage a une surface interne faisant face à la base et une surface externe faisant face à la partie avant de la coque. Un matériau de remplissage biocompatible, tel qu'un gel de silicone, est disposé à l'intérieur du volume intérieur de la coque. L'échafaudage a une forme qui reflète la forme de la partie avant de la coque. L'échafaudage renforce la coque pour fournir une stabilité de forme pour maintenir la forme de la coque et réduire au minimum le pliage, le capitonnage et/ou le plissement de la coque. L'échafaudage a une ou plusieurs ouvertures formées à l'intérieur de celui-ci pour permettre au matériau de charge biocompatible de remplir la ou les ouvertures. Un second échafaudage peut être emboîté à l'intérieur du premier échafaudage. Le second échafaudage a une dimension externe plus petite qu'une dimension interne du premier échafaudage.
PCT/IB2023/050258 2022-01-25 2023-01-11 Dispositifs prothétiques implantables ayant des coques externes avec échafaudage intégré pour améliorer la stabilité de forme, réduire le plissement et réduire le poids des dispositifs prothétiques implantables WO2023144642A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202263302692P 2022-01-25 2022-01-25
US63/302,692 2022-01-25
US17/965,961 2022-10-14
US17/965,961 US20230233737A1 (en) 2022-01-25 2022-10-14 Implantable prosthetic devices having outer shells with integrated scaffolding for improving form stability, reducing wrinkling and reducing the weight of the implantable prosthetic devices

Publications (1)

Publication Number Publication Date
WO2023144642A1 true WO2023144642A1 (fr) 2023-08-03

Family

ID=85018882

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2023/050258 WO2023144642A1 (fr) 2022-01-25 2023-01-11 Dispositifs prothétiques implantables ayant des coques externes avec échafaudage intégré pour améliorer la stabilité de forme, réduire le plissement et réduire le poids des dispositifs prothétiques implantables

Country Status (1)

Country Link
WO (1) WO2023144642A1 (fr)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472226A (en) 1979-10-03 1984-09-18 Minnesota Mining And Manufacturing Company Silicone gel filled prosthesis
US4605412A (en) * 1983-01-20 1986-08-12 Medical Engineering Corp. Mammary prosthesis having adjustable projection
US4773909A (en) * 1981-10-06 1988-09-27 Memorial Hospital For Cancer And Allied Diseases Multi-lumen high profile mammary implant
US5358521A (en) * 1992-04-01 1994-10-25 Fred Shane Multiple-layer prosthesis implant with tissue tactility
US6187043B1 (en) * 1987-12-22 2001-02-13 Walter J. Ledergerber Implantable prosthetic device
WO2011097292A1 (fr) * 2010-02-05 2011-08-11 Allergan, Inc. Prothèses gonflables et procédés de fabrication de celles-ci
US20130116784A1 (en) * 2011-11-09 2013-05-09 Ideal Implant Incorporated Breast Implant with Low Coefficient of Friction Between Internal Shells in an Aqueous Fluid Environment
US20140088703A1 (en) 2008-11-11 2014-03-27 Allergan, Inc. Soft prosthetic implant manufacturing process
US10898313B2 (en) 2018-08-10 2021-01-26 Mentor Worldwide Llc Systems, devices and methods of making mammary implants and tissue expanders having ribbed shells

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472226A (en) 1979-10-03 1984-09-18 Minnesota Mining And Manufacturing Company Silicone gel filled prosthesis
US4773909A (en) * 1981-10-06 1988-09-27 Memorial Hospital For Cancer And Allied Diseases Multi-lumen high profile mammary implant
US4605412A (en) * 1983-01-20 1986-08-12 Medical Engineering Corp. Mammary prosthesis having adjustable projection
US6187043B1 (en) * 1987-12-22 2001-02-13 Walter J. Ledergerber Implantable prosthetic device
US5358521A (en) * 1992-04-01 1994-10-25 Fred Shane Multiple-layer prosthesis implant with tissue tactility
US20140088703A1 (en) 2008-11-11 2014-03-27 Allergan, Inc. Soft prosthetic implant manufacturing process
WO2011097292A1 (fr) * 2010-02-05 2011-08-11 Allergan, Inc. Prothèses gonflables et procédés de fabrication de celles-ci
US20130116784A1 (en) * 2011-11-09 2013-05-09 Ideal Implant Incorporated Breast Implant with Low Coefficient of Friction Between Internal Shells in an Aqueous Fluid Environment
US10898313B2 (en) 2018-08-10 2021-01-26 Mentor Worldwide Llc Systems, devices and methods of making mammary implants and tissue expanders having ribbed shells

Similar Documents

Publication Publication Date Title
US20240041586A1 (en) Soft filled prosthesis shell with discrete fixation surfaces
US10864661B2 (en) Device and method for making a variable surface breast implant
US6605116B2 (en) Reinforced radius mammary prostheses and soft tissue expanders
US9808338B2 (en) Soft filled prosthesis shell with variable texture
EP2286761B1 (fr) Implant mammaire stable de forme et à gel de cohésion variable
US7520896B2 (en) Breast implant, use of an associated pouch, and method for determination of a breast implant
EP0174141B1 (fr) Dispositif de prothèse implantable
EP2531254B1 (fr) Orifice d'accès sous cutané implantable
US10898313B2 (en) Systems, devices and methods of making mammary implants and tissue expanders having ribbed shells
EP3125825B1 (fr) Expanseur tissulaire directionnel
US20010010024A1 (en) Tissue expander
US20030093151A1 (en) Implantable mammary prosthesis with flexible sheet
US20230233307A1 (en) Implantable prosthetic devices having outer shells with integrated scaffolding for improving form stability, reducing wrinkling and reducing the weight of the implantable prosthetic devices
US20120165934A1 (en) Collapsible, form-stable, fillable breast prosthesis
JPS5936532B2 (ja) 豊胸用插入体
AU2010284503A1 (en) Reinforced prosthetic implant with flexible shell
US20230233737A1 (en) Implantable prosthetic devices having outer shells with integrated scaffolding for improving form stability, reducing wrinkling and reducing the weight of the implantable prosthetic devices
WO2023144642A1 (fr) Dispositifs prothétiques implantables ayant des coques externes avec échafaudage intégré pour améliorer la stabilité de forme, réduire le plissement et réduire le poids des dispositifs prothétiques implantables
US20200405472A1 (en) Impermeable inner shell for a breast implant
WO2023144731A1 (fr) Dispositifs prothétiques implantables ayant des coques externes avec échafaudage intégré pour améliorer la stabilité de forme, réduire le plissement et réduire le poids des dispositifs prothétiques implantables

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23701194

Country of ref document: EP

Kind code of ref document: A1